MIRA INFORM REPORT

 

 

Report Date :

03.08.2012

 

IDENTIFICATION DETAILS

 

Name :

RAM PHARMACEUTICAL INDUSTRIES CO LTD

 

 

Registered Office :

King Abdullah II Industrial City, Street No. 5, Amman Industrial Estate, Sahab 211, Amman 11512

 

 

Country :

Jordan

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

05.09.1992

 

 

Com. Reg. No.:

2939, Amman

 

 

Legal Form :

Closed Shareholding Company

 

 

Line of Business :

Manufacture of therapeutic products

 

 

No. of Employees :

300

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Jordan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

SUMMARY

 

Company Name                         : RAM PHARMACEUTICAL INDUSTRIES CO LTD

Country of Origin                                    : Jordan

Legal Form                                            : Closed Shareholding Company

Registration Date                                   : 5th September 1992

Commercial Registration Number            : 2939, Amman

Membership Number                              : 7495

National ID Number                                : 200011910

Issued Capital                                        : JD 5,600,000

Paid up Capital                                      : JD 5,600,000

Total Workforce                                     : 300

Activities                                               : Manufacture of therapeutic products.

Financial Condition                                 : Good

Payments                                             : Nothing detrimental uncovered

Operating Trend                         : Steady

 

COMPANY NAME

 

RAM PHARMACEUTICAL INDUSTRIES CO LTD

 

 

ADDRESS

 

Registered & Physical Address

 

Location            : King Abdullah II Industrial City, Street No. 5

Area                 : Amman Industrial Estate, Sahab

 

PO Box             : 211

 

Town                 : Amman 11512

Country             : Jordan

 

Telephone         : (962-6) 4023950 / 4023951 / 4023952

Facsimile          : (962-6) 4023749

Email                : info@ram-pharma.com

 

Premises

 

Subject operates from a large suite of offices and a factory that are rented and located in the Industrial Area of Amman.

 

Branch Office (s)

 

     Location                                                                                           Description

 

·       Khaleel Al Salem Street                                                                     Rented office premises

     Tal Al Ali Area

     Amman

     Tel: (962-6) 5340165 / 5340216

     Fax: (962-6) 5340439

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Mahmoud Mohamed Rashdi El Nejmi                                                  Managing Director

 

·       Mohamed Rashdi El Nejmi                                                                 Director

 

·       Naji Mohamed El Jundi                                                                      Director

 

·       Munther Thabet El Khalidi                                                                  Director

 

·       Wessam Mohamed Rashdi El Nejmi                                                   Director

 

·       Dr Aref Al Zayed                                                                                Commercial Manager

 

·       Bassam Rabiyah                                                                               Finance Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 5th September 1992

 

Legal Form                  : Closed Shareholding Company

 

Commercial Reg. No.  : 2939, Amman

 

Membership No.          : 7495

 

National ID No.            : 200011910

 

Issued Capital              : JD 5,600,000

 

Paid up Capital            : JD 5,600,000

 

Name of Shareholder (s)

 

·       Mahmoud Mohamed Rashdi El Nejmi

 

·       Mohamed Rashdi El Nejmi

 

·       Naji Mohamed El Jundi

 

·       Munther Thabet El Khalidi

 

·       Wessam Mohamed Rashdi El Nejmi

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of a wide range of therapeutic products, including anti-microbial agents,
anxiolytes & anti-depressants, CNS stimulants, anti-hypertensive agents, hormones, analgesics & anti-
inflammatory agents, drugs for respiratory & gastrointestinal systems, anti-hyperglycaemic, diuretics and anti-gout preparations.

 

Subject is ISO 9002 accredited.

 

Import Countries: India and Europe

 

Export Countries: Algeria, Yemen, Iraq, Lebanon, Sudan, Saudi Arabia, Oman, Bahrain and the United Arab

                                    Emirates

 

Operating Trend: Steady

 

Subject has a workforce of approximately 300 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Jordanian Dinars (JD)

 

                                                             Year Ending 31/12/10:                             Year Ending 31/12/11:

 

Total Sales                                             JD 13,700,000                                         JD 14,250,000

 

Local sources consider subject’s financial condition to be Good.

 

 

BANKERS

 

·       Arab Bank Plc

Shmeisani Branch

PO Box: 950545 & 950544

Amman 11195

Tel: (962-6) 5607231 / 5607115

Fax: (962-6) 5606793 / 5606830

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Established in 1992, subject is involved in the manufacture of a wide range of therapeutic products, including anti-microbial agents, anxiolytes & anti-depressants, CNS stimulants, anti-hypertensive agents, hormones, analgesics & anti-inflammatory agents, drugs for respiratory & gastrointestinal systems, anti-hyperglycaemic, diuretics and anti-gout preparations.

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk and the above credit figure is deemed to be within subject’s financial means.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.55.77

UK Pound

1

Rs.86.74

Euro

1

Rs.68.31

 

 

INFORMATION DETAILS

 

Report Prepared by :

PDT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)         Ownership background (20%)                  Payment record (10%)

Credit history (10%)                 Market trend (10%)                                 Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.